Juichi Awaya is a prominent inventor based in Nagoya, Japan. He has made significant contributions to the field of protein research, holding a total of 5 patents. His work focuses on developing novel proteins with therapeutic applications, particularly in wound healing and immune system modulation.

Latest Patents

One of Awaya's latest patents involves a protein derived from Clostridium perfringens FERM BP-4584. This protein has a molecular weight of 420,000 ± 40,000, with an isoelectric point of 4.8. It consists of a single subunit with a molecular weight of 130,000 ± 20,000, as determined by SDS-polyacrylamide gel electrophoresis. The protein exhibits cell growth-stimulating activity and macrophage chemotactic action, making it a promising candidate for treating wounds and ulcers. Another notable patent describes a composition containing an organogermanium compound, which serves as an immunity adjusting agent. This composition is particularly relevant for the treatment of hepatitis.

Career Highlights

Juichi Awaya is associated with Sanwa Kagaku Kenkyusho Co., Ltd., where he continues to advance his research in protein applications. His innovative work has garnered attention in the scientific community, contributing to the understanding of protein functions in medical treatments.

Collaborations

Awaya has collaborated with notable colleagues such as Kiichi Sawai and Masayasu Kurono. Their combined expertise has furthered research initiatives and enhanced the development of new therapeutic solutions.

Conclusion

Juichi Awaya's contributions to protein research highlight his role as an influential inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com